Theragen BiO Institute TBI

Suigen, South Korea

Theragen BiO Institute TBI

Suigen, South Korea

Time filter

Source Type

Cheon C.K.,Pusan National University | Sohn Y.B.,Ajou University | Ko J.M.,Seoul National University | Lee Y.J.,Pusan National University | And 7 more authors.
Journal of Human Genetics | Year: 2014

Kabuki syndrome (KS) (OMIM#147920) is a multiple congenital anomaly/mental retardation syndrome. Recently, pathogenic variants in KMT2D and KDM6A were identified as the causes of KS in 55.8-80.0% of patients. To elucidate further the molecular characteristics of Korean patients with KS, we screened a cohort of patients with clinically defined KS for mutations in KMT2D and KDM6A. Whole-exome sequencing and direct sequencing for validation were performed in 12 patients with a clinical suspicion of KS. KMT2D and KDM6A mutations were identified in 11 (91.7%) patients. No recurrent mutation was observed, and 10 out of the 11 mutations found were novel. KMT2D mutations were detected in 10 patients, including four small deletions or insertions and four nonsense and two missense mutations. One girl had a novel splice-site mutation in KDM6A. Each patient had a unique individual mutation. This is the first report of mutational analysis via exome sequencing in Korean patients with KS. Because the mutation-detection rate was high in this study, rigorous mutation analysis of KMT2D and KDM6A may be an important tool for the early diagnosis and genetic counseling of Korean patients with KS. © 2014 The Japan Society of Human Genetics. All rights reserved.

Loading Theragen BiO Institute TBI collaborators
Loading Theragen BiO Institute TBI collaborators